CAS: 2086772-26-9
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
JNJ-64619178 REF: TM-T15624CAS: 2086772-26-9 | 98.44% - 99.63% | 85.00 €~602.00 € | Thu 10 Oct 24 | |
JNJ-64619178 REF: 3D-LID77226CAS: 2086772-26-9 | Min. 95% | To inquire | Fri 29 Nov 24 |
JNJ-64619178
CAS:2086772-26-9
JNJ-64619178: selective, oral, pseudo-irreversible PRMT5 inhibitor (IC50: 0.14 nM), effective in lung cancer.
Formula:
C22H23BrN6O2
Purity:
98.44% - 99.63%
Color and Shape:
Solid
Molecular weight:
483.36
Ref: TM-T15624
1mg | 85.00 € | ||
1ml | 182.00 € | ||
5mg | 172.00 € | ||
10mg | 245.00 € | ||
25mg | 408.00 € | ||
50mg | 602.00 € |
Estimated delivery in United States, on Thursday 10 Oct 2024
JNJ-64619178
CAS:2086772-26-9
JNJ-64619178 is a novel small molecule that targets the methyltransferase domain of the protein PRMT5. …
Formula:
C22H23BrN6O2
Purity:
Min. 95%
Molecular weight:
483.36 g/mol
Ref: 3D-LID77226
1mg | 252.00 € | ||
2mg | 370.00 € | ||
5mg | 527.00 € | ||
10mg | 753.00 € | ||
25mg | 1,121.00 € |
Estimated delivery in United States, on Friday 29 Nov 2024